Oct 19, 2021
1 mins read
$4 million for Psychedelic Treatment Research is funded by NIH’s National Institute on Drug Abuse.
The question that remains to be answered:
❓Can psilocybin help smokers quit?
❓Are psilocybin mushrooms - at the same dose of psilocybin - less, equal or more beneficial than pure psilocybin?
"This is the first NIH grant awarded in over a half century to directly investigate the therapeutic effects of a classic psychedelic, consistent with a recent study published online that searched NIH funding and found zero grants were awarded between 2006 and 2020.
Johns Hopkins Medicine will lead the multisite, three-year study in collaboration with University of Alabama at Birmingham and New York University. The study will be conducted simultaneously at the three institutions to diversify the pool of participants and increase confidence that results apply to a wide range of people who smoke."
Researchers suggest psilocybin can break behavior patterns and help people to quit bad habits.
Psilocybin in combination with proper therapy preparation and structured support has shown promise for treatment of a range of addictions and mental health disorders.
❗️This research is supported by the National Institute on Drug Abuse of the National Institutes of Health under award number U01DA052174. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Check out full original article:
Paul Stamets commented these news in his Instagram
Looking forward for new discoveries in the world of psychedelics! Peace 🙏
© Shroomok - Mushroom Cultivation Guide